Science Daily15h
A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Guidelines needed for interpreting continuous glucose monitoring reports in those without diabetes, say researchers
With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...
Healio17h
Living kidney donors with discordant kidney function measures had low post-donation eGFR
Living kidney donors with discordant kidney function measures had lower eGFR after donation and a higher risk for eGFR counts ...
Cochrane19h
Does treatment with GLP-1 receptor agonists prevent complications for people with chronic kidney disease and diabetes?
• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...
ophthalmologyadvisor15h
Ocular Biomarker for Anemia Severity in Diabetic Kidney Disease Detectable on OCT
Ocular biomarkers for anemia in diabetic kidney disease include disruption of the external limiting membrane and ellipsoid zone.